19 June 2013
Keywords: R&A oursourcing, Shifting to China and India, Booz & Co
Article | 08 March 2012
As biopharmaceutical companies look to cut costs and improve speed-to-market, more of them plan to outsource R&D and ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 March 2012
9 March 2012
18 June 2013
© 2013 thepharmaletter.com